MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    GPi DBS for refractory dystonia 4 years after STN DBS on a Parkinson’s Disease patient

    B. Meira, A. Santos, C. Reizinho, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

    Objective: Describe a case of unilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for refractory dystonia after subthalamic nucleus (STN) DBS on a Parkinson…
  • MDS Virtual Congress 2021

    Deep brain stimulation improves gait velocity acutely in patients with Parkinson’s disease

    S. Miocinovic, L. Mckay, F. Isbaine, J. Nocera, J. Tran, S. Triche, C. Esper, P. Aia, L. Scorr, L. Higginbotham, C. Buetefisch (Atlanta, USA)

    Objective: To systematically investigate the acute (5 minutes) and chronic (1 month) effects of deep brain stimulation (DBS) of subthalamic nucleus (STN) and globus pallidus…
  • MDS Virtual Congress 2021

    DBS Directional programming – Institution based study of programming in PD and ET patients

    M. Moreno-Escobar, R. Elkins, S. Pallavaram, R. Tripathi (Morgantown, USA)

    Objective: To examine the use of Deep Brain Stimulation (DBS) directional programming in Parkinson Disease (PD) and Essential Tremor (ET) patients Background: DBS and its utility…
  • MDS Virtual Congress 2021

    Combined effects of GBA mutations and STN-DBS negatively impact cognition in Parkinson’s disease

    G. Pal, G. Mangone, E. Hill, V. Lythe, D. Ehrlich, R. Saunders-Pullman, V. Shanker, S. Bressman, R. Alcalay, P. Garcia, K. Marder, J. Aasly, M. Mouradian, B. Ouyang, Y. Liu, S. Ruehl, M. Rosenbaum, S. Anderson, B. Bernard, D. Hall, S. Sani, L. Verhagen, R. Debie, T. Foltynie, J. Corvol, C. Goetz (New Brunswick, USA)

    Objective: To compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and non-carriers with and without subthalamic nucleus deep brain stimulation (STN-DBS)…
  • MDS Virtual Congress 2021

    Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Movement Disorders in a Canadian Center

    S. Poonja, K. Yen, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: To study disparities in gender and ethnicity among deep brain stimulation (DBS) patients to reduce differences in access to care by eventually implementing strategies…
  • MDS Virtual Congress 2021

    Quality of life after Globus Pallidus vs Subthalamic nucleus DBS; insights from the Parkinson’s Outcomes Project registry.

    A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, M. Neault, A. Naito, J. Beck, R. de Leon, S. Wu, C. Marras, T. Thomas (Gainesville, USA)

    Objective: To assess differences in quality of life between Globus Pallidus internus (Gpi) or Subthalamic (STN) nucleus deep brain stimulation (DBS) in Parkinson’s Disease (PD)…
  • MDS Virtual Congress 2021

    Successful external defibrillation in a patient with bilateral deep brain stimulation

    J. Sadasivan, J. Wong, T. Stiep, A. Patterson, L. Almeida (Gainesville, USA)

    Objective: To report outcomes regarding deep brain stimulation (DBS) hardware integrity and preservation of program settings in a Parkinson’s Disease (PD) patient with bilateral globus…
  • MDS Virtual Congress 2021

    BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A PATIENT WITH PARKINSON DISEASE AND INTOLERANCE TO STANDARD ANTIPARKINSONIAN DRUGS – A CASE REPORT

    M. Tsalta-Mladenov, V. Dimitrova, M. Moynov, S. Andonova, Y. Enchev (Varna, Bulgaria)

    Objective: We present a case of a 59-year-old PD patient with severe intolerance to the standard anti-Parkinsonian drugs (APDs) including levodopa (L-DOPA), MAO-B inhibitors, and…
  • MDS Virtual Congress 2021

    Predicting MDS-UPDRS Ratings for Deep Brain Stimulation Patients Using Wearable Sensor Data

    J. Watts, A. Khojandi, M. Niethammer, R. Ramdhani (Knoxville, USA)

    Objective: To predict gait and speech scores of the (MDS)-Unified Parkinson’s Disease Rating Scale (UPDRS) for chronic subthalamic deep brain stimulation (STN-DBS) patients using wearable…
  • MDS Virtual Congress 2021

    Review of intraoperative computed tomography accuracy for deep brain stimulation lead verification

    Y. Willems, F. Steup, Z. Vallinga, C. Hoffmann, R. Zutt, M. Contarino, N. vd Gaag (The Hague, Netherlands)

    Objective: Systematic review of literature to verify accuracy of iCT for the anatomical target in DBS surgery. Background: Accurate lead placement is crucial to maximize…
  • « Previous Page
  • 1
  • …
  • 534
  • 535
  • 536
  • 537
  • 538
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley